Low-dose methazolamide and intraocular pressure

Richard A. Stone; Thom J. Zimmerman; Dong H. Shin; Bernard Becker; Michael A. Kass

doi:10.1016/0002-9394(77)90134-9

Low-dose methazolamide and intraocular pressure

Richard A. Stone
, Thom J. Zimmerman
, Dong H. Shin
, Bernard Becker
, Michael A. Kass

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Abstract

Sixteen patients with increased intraocular pressure (over 20 mm Hg) received 25 and 50 mg of oral methazolamide, twice daily, during consecutive weeks and then 500 mg (Sequels) of acetazolamide. The two methazolamide regimens produced significant decreases in intraocular pressure. Acetazolamide treatment resulted in a greater decrease in intraocular pressure but more systemic acidosis and side effects.

Original language	English
Pages (from-to)	674-679
Number of pages	6
Journal	American journal of ophthalmology
Volume	83
Issue number	5
DOIs	https://doi.org/10.1016/0002-9394(77)90134-9
State	Published - May 1977

Access to Document

10.1016/0002-9394(77)90134-9

Cite this

@article{da72918a087f4150baff7716c6202366,

title = "Low-dose methazolamide and intraocular pressure",

abstract = "Sixteen patients with increased intraocular pressure (over 20 mm Hg) received 25 and 50 mg of oral methazolamide, twice daily, during consecutive weeks and then 500 mg (Sequels) of acetazolamide. The two methazolamide regimens produced significant decreases in intraocular pressure. Acetazolamide treatment resulted in a greater decrease in intraocular pressure but more systemic acidosis and side effects.",

author = "Stone, \{Richard A.\} and Zimmerman, \{Thom J.\} and Shin, \{Dong H.\} and Bernard Becker and Kass, \{Michael A.\}",

note = "Funding Information: From the Glaucoma Center, Washington University School of Medicine, St. Louis, Missouri. This study was supported in part by grant EY 00336 from the National Eye Institute; by a grant from Research to Prevent Blindness, Inc., New York, New York; and by a fellowship grant from Fight For Sight, Inc., New York, New York (Dr. Shin). Dr. Zimmerman is a Heed Fellow (1976-1977). Reprint requests to Bernard Becker, M.D., Glaucoma Center, Washington University School of Medicine, 660 S. Euclid, St. Louis, MO 63110.",

year = "1977",

month = may,

doi = "10.1016/0002-9394(77)90134-9",

language = "English",

volume = "83",

pages = "674--679",

journal = "American journal of ophthalmology",

issn = "0002-9394",

number = "5",

}

TY - JOUR

T1 - Low-dose methazolamide and intraocular pressure

AU - Stone, Richard A.

AU - Zimmerman, Thom J.

AU - Shin, Dong H.

AU - Becker, Bernard

AU - Kass, Michael A.

N1 - Funding Information: From the Glaucoma Center, Washington University School of Medicine, St. Louis, Missouri. This study was supported in part by grant EY 00336 from the National Eye Institute; by a grant from Research to Prevent Blindness, Inc., New York, New York; and by a fellowship grant from Fight For Sight, Inc., New York, New York (Dr. Shin). Dr. Zimmerman is a Heed Fellow (1976-1977). Reprint requests to Bernard Becker, M.D., Glaucoma Center, Washington University School of Medicine, 660 S. Euclid, St. Louis, MO 63110.

PY - 1977/5

Y1 - 1977/5

N2 - Sixteen patients with increased intraocular pressure (over 20 mm Hg) received 25 and 50 mg of oral methazolamide, twice daily, during consecutive weeks and then 500 mg (Sequels) of acetazolamide. The two methazolamide regimens produced significant decreases in intraocular pressure. Acetazolamide treatment resulted in a greater decrease in intraocular pressure but more systemic acidosis and side effects.

AB - Sixteen patients with increased intraocular pressure (over 20 mm Hg) received 25 and 50 mg of oral methazolamide, twice daily, during consecutive weeks and then 500 mg (Sequels) of acetazolamide. The two methazolamide regimens produced significant decreases in intraocular pressure. Acetazolamide treatment resulted in a greater decrease in intraocular pressure but more systemic acidosis and side effects.

UR - https://www.scopus.com/pages/publications/0017654388

U2 - 10.1016/0002-9394(77)90134-9

DO - 10.1016/0002-9394(77)90134-9

M3 - Article

C2 - 17301

AN - SCOPUS:0017654388

SN - 0002-9394

VL - 83

SP - 674

EP - 679

JO - American journal of ophthalmology

JF - American journal of ophthalmology

IS - 5

ER -

Low-dose methazolamide and intraocular pressure

Abstract

Access to Document

Other files and links

Fingerprint

Cite this